Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane A Mitchell

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|March 17, 2016
MicroRNAs provide a novel pathway toward combinatorial immune checkpoint blockadeDuane A Mitchell
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumorsRebecca Liu, Duane A Mitchell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Is cytomegalovirus a therapeutic target in glioblastoma?John H Sampson, Duane A Mitchell
Neuro-Oncology|October 31, 2015
Vaccination strategies for neuro-oncologyJohn H Sampson, Duane A Mitchell
Advances in Experimental Medicine and Biology|May 29, 2012
Monoclonal antibody therapy for malignant gliomaKevin S Chen, Duane A Mitchell
Oncoimmunology|December 22, 2016
Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroupsChristina D Pham, Duane A Mitchell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2022
Cellular Cancer Immunotherapy Development and Manufacturing in the ClinicGraeme A Fenton, Duane A Mitchell
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Toward effective immunotherapy for the treatment of malignant brain tumorsDuane A Mitchell, John H Sampson
Journal of Immunology Research|March 8, 2017
Manipulation of Innate and Adaptive Immunity through Cancer VaccinesElias J Sayour, Duane A Mitchell
Immunotherapy|April 20, 2012
Chasing cancer with chimeric antigen receptor therapyChristina D Pham, Duane A Mitchell
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|March 17, 2016
MicroRNAs provide a novel pathway toward combinatorial immune checkpoint blockadeDuane A Mitchell
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumorsRebecca Liu, Duane A Mitchell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Is cytomegalovirus a therapeutic target in glioblastoma?John H Sampson, Duane A Mitchell
Neuro-Oncology|October 31, 2015
Vaccination strategies for neuro-oncologyJohn H Sampson, Duane A Mitchell
Advances in Experimental Medicine and Biology|May 29, 2012
Monoclonal antibody therapy for malignant gliomaKevin S Chen, Duane A Mitchell
Oncoimmunology|December 22, 2016
Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroupsChristina D Pham, Duane A Mitchell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2022
Cellular Cancer Immunotherapy Development and Manufacturing in the ClinicGraeme A Fenton, Duane A Mitchell
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Toward effective immunotherapy for the treatment of malignant brain tumorsDuane A Mitchell, John H Sampson
Journal of Immunology Research|March 8, 2017
Manipulation of Innate and Adaptive Immunity through Cancer VaccinesElias J Sayour, Duane A Mitchell
Immunotherapy|April 20, 2012
Chasing cancer with chimeric antigen receptor therapyChristina D Pham, Duane A Mitchell
Pageof 13